-The Economic Times Foreign pharma companies could be forced to overhaul their strategy for the Indian market by striking more local deals and cutting sky-high drug prices after the Supreme Court slammed the door on Swiss giant Novartis' attempts to gain a patent for its blood cancer-busting drug Glivec. But the ruling, welcomed by activists campaigning for affordable drugs and local generic companies, threatened to reinforce a narrative that India...
More »SEARCH RESULT
SC’s Glivec ruling setback to foreign pharma firms -Vidya Krishnan and CH Unnikrishnan
-Live Mint SC rejects Novartis's patent plea for Glivec, says it does not meet any standard of novelty or inventiveness In a landmark judgement, India's apex court rejected Swiss drug maker Novartis AG's legal challenge aimed at securing a patent for blockbuster anti-cancer drug imatinib mesylate, branded Glivec in the country. The verdict, which is seen as a setback to multinational pharmaceutical companies operating in India, may influence a rash of pending disputes...
More »SC verdict on Novartis AG plea today
-Reuters Global drugmakers, battered by recent intellectual property decisions in the country, are girding for a landmark court ruling on Monday with broad consequences for their ability to sell lucrative patented medicines in the country. Supreme Court is due to decide on April 1 whether or not Swiss giant Novartis AG's cancer treatment Glivec deserves a patent in the country. "Big Pharma is nervous because nothing has gone in their favour in the...
More »THOSE WHO MADE THE RIGHT KIND OF NOISE -Prasenjit Bose
-The Telegraph Many Indians stand in solidarity with the protest launched by the academic community in the University of Pennsylvania against the decision to invite Narendra Modi, writes Prasenjit Bose S L. Rao's criticisms of the academics of the University of Pennsylvania, who had initiated a campaign against Wharton Business School's invitation to Narendra Modi, in his article, "The trip that never was" (March 18), are not only unwarranted but they also...
More »Battle won for daughter in 34-yr dowry fight-Abantika Ghosh
-The Indian Express Thirty-four years after the death of 20-year-old Kanchanbala from 100 per cent burn injuries, and 27 years after her case led to changes in the dowry law, the Delhi High Court has upheld the conviction of her husband for abetment to suicide. In a verdict on the eve of Women's Day earlier this month, the court linked it to his demand for a scooter made two days before Kanchanbala's...
More »